FDA Releases Draft Guidance for Human Plasma-Derived Biological Products and Animal Plasma or Serum-Derived Products

Summary

The FDA is releasing a draft guidance document to help applicants prepare the required sections of a biologics license application for human plasma-derived biological products, animal plasma, or serum-derived products, aiming to reduce industry burdens while maintaining public health protection.